AR037457A1 - Compuestos derivados de benzotiazol, su empleo, un procedimiento para prepararlos y medicamentos que los contienen - Google Patents

Compuestos derivados de benzotiazol, su empleo, un procedimiento para prepararlos y medicamentos que los contienen

Info

Publication number
AR037457A1
AR037457A1 ARP020104580A ARP020104580A AR037457A1 AR 037457 A1 AR037457 A1 AR 037457A1 AR P020104580 A ARP020104580 A AR P020104580A AR P020104580 A ARP020104580 A AR P020104580A AR 037457 A1 AR037457 A1 AR 037457A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
disease
compounds
general formula
prepare
Prior art date
Application number
ARP020104580A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR037457A1 publication Critical patent/AR037457A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de fórmula general (1) en donde R1 es hidrógeno o alquilo inferior; R2 es alquilo inferior -(CH2)n-O-alquilo inferior, cicloalquilo de 3 a 6 átomos de carbono o -(CH2)n-NR'2; R' es hidrógeno, alquilo inferior o -(CH2)n-O-alquilo inferior, independientemente entre sí para R´2, o R´2 puede formar juntamente con el átomo de N un anillo de pirrolidina; n es 1,2 o 3; y las sales de adición ácida farmacéuticamente aceptables de los mismos. Su empleo, un procedimiento para prepararlos y medicamentos que los contienen. Los compuestos de fórmula general (1) son ligandos del receptor de la adenosina. Específicamente, tienen una buena afinidad para el receptor A2A y por lo tanto son útiles en el tratamiento de enfermedades relacionadas con este receptor tales como la enfermedad de Alzheimer, la enfermedad de Parkinson, la enfermedad de Huntington, neuroprotección, esquizofrenia, ansiedad, dolor, déficits de respiración, depresión, adicción a drogas tal como la anfetamina, cocaína, opioides, etanol, nicotina, cannabinoides, o contra el asma, respuestas alérgicas, hipoxia, isquemia, ataque cardíaco y abuso de substancias. Además, los compuestos de fórmula general (1) pueden ser de utilidad como sedativos, relajantes musculares, antipsicóticos, antipilépticos, anticonvulsivos y agentes cardioprotectores para trastornos tales como la enfermedad de las arterias coronarias y fallo cardíaco.
ARP020104580A 2001-11-29 2002-11-28 Compuestos derivados de benzotiazol, su empleo, un procedimiento para prepararlos y medicamentos que los contienen AR037457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01128338 2001-11-29

Publications (1)

Publication Number Publication Date
AR037457A1 true AR037457A1 (es) 2004-11-10

Family

ID=8179392

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104580A AR037457A1 (es) 2001-11-29 2002-11-28 Compuestos derivados de benzotiazol, su empleo, un procedimiento para prepararlos y medicamentos que los contienen

Country Status (20)

Country Link
US (1) US6624163B2 (es)
EP (1) EP1450797B1 (es)
JP (1) JP4146799B2 (es)
KR (1) KR100581704B1 (es)
CN (1) CN1304383C (es)
AR (1) AR037457A1 (es)
AT (1) ATE330603T1 (es)
AU (1) AU2002365506B2 (es)
BR (1) BR0214488A (es)
CA (1) CA2468311C (es)
DE (1) DE60212694T2 (es)
ES (1) ES2266608T3 (es)
MX (1) MXPA04005077A (es)
PA (1) PA8558701A1 (es)
PE (1) PE20030821A1 (es)
PL (1) PL373947A1 (es)
RU (1) RU2301232C2 (es)
TW (1) TW200408395A (es)
UY (1) UY27559A1 (es)
WO (1) WO2003045386A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004251002B2 (en) 2003-06-20 2009-10-29 F. Hoffmann-La Roche Ag 2-aminobenzothiazoles as CB1 receptor inverse agonists
KR20060058132A (ko) * 2003-09-19 2006-05-29 에프. 호프만-라 로슈 아게 아데노신 수용체 리간드로서의 싸이아졸로피리딘 유도체
TW200524887A (en) * 2003-10-27 2005-08-01 Lundbeck & Co As H N-thiazol-2-yl-benzamide derivatives
US7714009B2 (en) 2003-10-31 2010-05-11 Takeda Pharmaceutical Company Limited Nitrogen-containing fused heterocyclic compounds
EP1701951B1 (en) * 2003-12-23 2010-02-10 Serodus AS Modulators of peripheral 5-ht receptors
DE602005019408D1 (de) * 2004-07-22 2010-04-01 Hoffmann La Roche Benzothiazolderivate
RU2381227C2 (ru) 2004-07-22 2010-02-10 Ф. Хоффманн-Ля Рош Аг Замещенные бензотиазолы
EP1794157B1 (en) 2004-09-22 2014-02-26 H. Lundbeck A/S 2-acylaminothiazole derivatives
US7674912B2 (en) 2005-04-25 2010-03-09 H. Lundbeck A/S Pro-drugs of N-thiazol-2-yl-benzamide derivatives
WO2020103930A1 (zh) * 2018-11-22 2020-05-28 上海科技大学 噻唑并环类化合物、其制备方法、中间体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3374550D1 (en) 1982-12-21 1987-12-23 Johnsen Jorgensen Plastics Ltd Dispensing container
FI91859C (fi) 1987-06-17 1994-08-25 Eisai Co Ltd Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
IL90337A0 (en) * 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
WO1993023409A1 (en) * 1992-05-21 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative
CN1234358C (zh) 2000-06-21 2006-01-04 弗·哈夫曼-拉罗切有限公司 苯并噻唑衍生物

Also Published As

Publication number Publication date
CA2468311C (en) 2011-03-15
JP4146799B2 (ja) 2008-09-10
UY27559A1 (es) 2003-05-30
DE60212694T2 (de) 2007-06-28
RU2004119985A (ru) 2006-01-10
DE60212694D1 (de) 2006-08-03
US20030134855A1 (en) 2003-07-17
PE20030821A1 (es) 2003-10-04
KR100581704B1 (ko) 2006-05-22
CN1304383C (zh) 2007-03-14
BR0214488A (pt) 2004-10-19
TW200408395A (en) 2004-06-01
AU2002365506A1 (en) 2003-06-10
CA2468311A1 (en) 2003-06-05
AU2002365506B2 (en) 2006-08-10
KR20040062967A (ko) 2004-07-09
EP1450797B1 (en) 2006-06-21
ES2266608T3 (es) 2007-03-01
RU2301232C2 (ru) 2007-06-20
JP2005518363A (ja) 2005-06-23
WO2003045386A1 (en) 2003-06-05
CN1596112A (zh) 2005-03-16
MXPA04005077A (es) 2004-08-19
PL373947A1 (en) 2005-09-19
ATE330603T1 (de) 2006-07-15
EP1450797A1 (en) 2004-09-01
US6624163B2 (en) 2003-09-23
PA8558701A1 (es) 2003-09-05

Similar Documents

Publication Publication Date Title
AR037528A1 (es) Derivados de piridona de benzotiazol
BR0108611A (pt) Moduladores de receptor de adenosina
YU96502A (sh) Derivati benzotiazola
TWI255807B (en) Therapeutic agents
DK0975595T3 (da) Kokainanaloger
AR037457A1 (es) Compuestos derivados de benzotiazol, su empleo, un procedimiento para prepararlos y medicamentos que los contienen
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
JP2005502680A5 (es)
HUP0401201A2 (hu) Flibanserin stabil polimorfja, ipari eljárás előállítására és alkalmazása gyógyszerek előállítására
IL179160A0 (en) Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
WO2003077869A3 (en) Neuroprotective spirostenol pharmaceutical compositions
UY29823A1 (es) Derivados sustituidos de 7-cloro-3h-imidazol-(4,5-b) piridina, composiciones farmacéuticas que los contienen, procesos para la preparación de los mismos y aplicaciones
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
SE0104331D0 (sv) Novel compounds
MX9306234A (es) Oxindoles y azaoxoindoles 1-substituidos y composiciones farmaceuticas que los contienen.
BRPI0409308A (pt) derivados azabiciclo como antagonistas de receptores muscarìnicos, composição farmacêutica e processo para sua preparação
AR037221A1 (es) Compuestos derivados de piridina, uso de los mismos, un procedimiento para su preparacion y un medicamento que contiene uno o mas de dichos compuestos
SG140605A1 (en) Benzothiazole derivatives
AR037792A1 (es) Compuestos derivados de benzotiazol, su uso, un procedimiento para su obtencion y medicamentos que los contienen
AR049998A1 (es) BENZOTIAZOLES SUSTITUIDOS COMO LIGANDOS DEL RECEPTOR DE ADENOSINA, PROCESO DE PREPARACIoN Y SU USO
ATE468334T1 (de) Benzopyranylheterocyclylderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
BR0309025A (pt) Agentes antidiabéticos
AR037791A1 (es) Compuestos derivados de benzotiofeno, su empleo, un procedimiento para prepararlos y medicamentos que los contienen
UY27574A1 (es) Uso de ureas de benzotiazoles
BR0308987A (pt) Agentes antidiabéticos

Legal Events

Date Code Title Description
FB Suspension of granting procedure